Litigation

Recent Posts

California High Court Revives Baycol Class Action Appeal
Posted on 28 Feb 2011 by Tom Moylan

SAN FRANCISCO - (Mealey's) The California Supreme Court on Feb. 28 revived an appeal involving a Baycol heart drug state consumer class action, saying an appeals court misapplied the state's "death knell" doctrine about what claims can... Read More

Tags: cerivastatin , Business and Professions Code Section 17200 , heart drug , Consumer Legal Remedies Act , California , Douglas Shaw , unjust enrichment , class action , Bayer , unfair competition law , certification , California Supreme Court , “death knell” doctrine , Litigation , Civil Code Section 1750 , lawsuit , anti-cholesterol drug , Bayco , In Re Baycol Cases I and II

Supreme Court: Federal Court Erred In Precluding State Court Baycol Class Action
Posted on 16 Jun 2011 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) A unanimous U.S. Supreme Court ruled Jun. 16 that a federal court presiding over federal Baycol lawsuits improperly enjoined a West Virginia state court from considering a class action involving the heart drug ( Keith... Read More

Tags: Supreme Court , heart drug , West Virginia , class action , Keith Smith v. Bayer Corporation , Baycol , anti-cholesterol drug. Bayer , Shirley Sperlazza. Brook County Circuit Court , Litigation , Keith Smith

Scios To Plead Guilty, Pay $85 Million For Off-Label Marketing Of Natrecor
Posted on 15 Sep 2011 by Tom Moylan

SAN FRANCISCO -- The Scios Inc. subsidiary of Johnson & Johnson has agreed to plead guilty to a misdemeanor charge related to the off-label marketing of its Natrecor heart drug, to pay an $85 million fine and to serve three years' organizational... Read More

Tags: False Claims Act , heart drug , off-label marketing , United States of America v. Scios , Johnson , Natrecor , Food Drug and Cosmetic Act , Scios , Litigation , Johnson &amp